AnalystsSilvan TurkcanSilvan Turkcan's Stock Forecasts
AnalystsSilvan Turkcan
Sectors:
Industries:
Analyst Ranking
Top 47%
#2489 out of 5278 analysts
Average Return
+1.81%
Win Rate
56%5 out of 9
Risk vs Reward
Poor
Good
Silvan Turkcan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Relay Therapeutics IncRLAY | +18.91% | $10.26 | $12.20 | 2026-03-17 - 2026-05-15 | Buy |
Celcuity IncCELC | +9.55% | $125.68 | $137.68 | 2026-04-27 - 2026-05-15 | Buy |
Tuhura Biosciences IncHURA | +4.05% | $2.22 | $2.31 | 2026-04-27 - 2026-05-15 | Buy |
Intellia Therapeutics IncNTLA | +3.56% | $13.20 | $13.67 | 2026-04-28 - 2026-05-15 | Buy |
Intellia Therapeutics IncNTLA | +0.48% | $13.61 | $13.67 | 2026-03-03 - 2026-05-15 | Buy |
Silvan Turkcan Analyst Color
Get additional color on Silvan Turkcan's coverage of popular stocks
Silvan Turkcan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Celcuity IncCELC | 2 | Buy | $160.00 | +16.21% | Maintains | 13 days ago |
Relay Therapeutics IncRLAY | 2 | Buy | $19.00 | +55.74% | Maintains | 19 days ago |
Intellia Therapeutics IncNTLA | 2 | Buy | $30.00 | +119.46% | Maintains | 19 days ago |
Tuhura Biosciences IncHURA | 1 | Buy | $9.00 | +289.61% | Initiates Coverage On | 20 days ago |
Cellectis SaCLLS | 1 | Buy | $8.00 | +104.08% | Reiterates | a month ago |
Crispr Therapeutics AgCRSP | 1 | Buy | $80.00 | +65.26% | Maintains | 4 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.